MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
4.660
-0.120 (-2.51%)
Jun 25, 2026, 4:00 PM EDT - Market closed
MacroGenics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 157.08 | 149.5 | 149.96 | 58.75 | 151.94 | 77.45 | |
Revenue Growth (YoY) | 1.97% | -0.31% | 155.26% | -61.33% | 96.19% | -26.16% |
Cost of Revenue | 40.14 | 36.01 | 12.3 | 8.22 | 7.38 | 2.65 |
Gross Profit | 116.94 | 113.49 | 137.66 | 50.53 | 144.56 | 74.8 |
Selling, General & Admin | 38.15 | 39.16 | 71.05 | 52.19 | 58.95 | 63.01 |
Research & Development | 142.45 | 147.17 | 177.19 | 166.58 | 207.03 | 214.58 |
Total Operating Expenses | 180.6 | 186.33 | 248.24 | 218.77 | 265.98 | 277.59 |
Operating Income | -63.66 | -72.84 | -110.58 | -168.24 | -121.42 | -202.8 |
Interest Income | 5.93 | 6.06 | 9.42 | 9.69 | 1.66 | 0.68 |
Interest Expense | -13.31 | -8.51 | -1.12 | -1.43 | - | - |
Other Non-Operating Income (Expense) | - | - | 36.25 | 150.93 | - | - |
Total Non-Operating Income (Expense) | -7.37 | -2.45 | 44.56 | 159.19 | 1.66 | 0.68 |
Pretax Income | -34.26 | -75.29 | -66.02 | -9.06 | -119.76 | -202.12 |
Provision for Income Taxes | -0.67 | -0.67 | 0.94 | - | - | - |
Net Income | -33.58 | -74.62 | -66.97 | -9.06 | -119.76 | -202.12 |
Net Income to Common | -70.36 | -74.62 | -66.97 | -9.06 | -119.76 | -202.12 |
Shares Outstanding (Basic) | 63 | 63 | 63 | 62 | 61 | 60 |
Shares Outstanding (Diluted) | 63 | 63 | 63 | 62 | 61 | 60 |
Shares Change (YoY) | 0.74% | 0.85% | 1.12% | 0.81% | 2.48% | 14.31% |
EPS (Basic) | -1.10 | -1.18 | -1.07 | -0.15 | -1.95 | -3.37 |
EPS (Diluted) | -1.10 | -1.18 | -1.07 | -0.15 | -1.95 | -3.37 |
Free Cash Flow | -71.69 | -82.95 | -72.08 | -79.97 | -90.58 | -150.03 |
Free Cash Flow Per Share | -1.13 | -1.31 | -1.15 | -1.29 | -1.47 | -2.50 |
Gross Margin | 74.45% | 75.91% | 91.80% | 86.00% | 95.14% | 96.58% |
Operating Margin | -40.53% | -48.72% | -73.74% | -286.38% | -79.91% | -261.85% |
Profit Margin | -21.38% | -49.91% | -44.66% | -15.42% | -78.82% | -260.97% |
FCF Margin | -45.64% | -55.49% | -48.06% | -136.12% | -59.62% | -193.72% |
EBITDA | -56.57 | -65.67 | -103.04 | -158.6 | -109.55 | -191.54 |
EBITDA Margin | -36.01% | -43.93% | -68.71% | -269.96% | -72.10% | -247.31% |
EBIT | -63.66 | -72.84 | -110.58 | -168.24 | -121.42 | -202.8 |
EBIT Margin | -40.53% | -48.72% | -73.74% | -286.38% | -79.91% | -261.85% |
Effective Tax Rate | 1.96% | 0.89% | -1.43% | 0.00% | 0.00% | 0.00% |